Eli Lilly and Company (NYSE:LLY) will look for acquisition opportunities. Eli Lilly will consider more acquisitions similar to its $1.6 billion purchase of Armo Biosciences earlier this year. Eli Lilly Chief Financial Officer Joshua Smiley said, "The Armo deal that we did earlier this year, we’ll look to do more of those."